UHND.com - Notre Dame Football, Basketball, & Recruiting

AI Overview


+21
Yes, there can be conflicts of interest between the FDA and pharmaceutical companies. These arise when individuals involved in the FDA's drug approval process have financial or other relationships with pharmaceutical companies whose products they are reviewing.
Here's a breakdown of the potential conflicts:
1. Financial Ties:
Advisory Committee Members:
FDA advisory committees play a crucial role in drug approvals, and members may have financial relationships with pharmaceutical companies, including research grants, consulting fees, or stock ownership.
FDA Staff:
FDA employees, including reviewers, may also have financial ties to the pharmaceutical industry, creating a potential conflict of interest when they are involved in drug approvals.
"Revolving Door":
A concerning trend is the movement of former FDA employees into high-paying positions at pharmaceutical companies, particularly after involvement in drug approvals.